Sibutramine treatment in obesity: Predictors of weight loss including Rorschach personality data

Obesity Research

Volumn 11, Issue 11, 2003, Pages 1391-1399

  Elfhag, Kristina ^a   Rössner, Stephan ^a   Carlsson, Anna Maria ^b   Barkeling, Britta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Appetite; Drug treatment; Eating behavior; Pharmacological treatment; Psychology

Indexed keywords

ANIMALIA;

CYCLOBUTANE DERIVATIVE; SIBUTRAMINE;

ADULT; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; PERSONALITY; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; SATIETY; STATISTICAL MODEL; WEIGHT REDUCTION;

ADULT; CYCLOBUTANES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; PERSONALITY; RORSCHACH TEST; SATIATION; WEIGHT LOSS;

EID: 1542650199     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2003.188     Document Type: Article

References (53)

1. Heal DJ, Aspley S, Prow M, Jackson H, Martin K, Cheetham S. Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int J Obes. 1998;22:S18-29.
2. James WPT, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet. 2000;356:2119-25.
3. McNeely W, Goa KL. Sibutramine: a review of its contribution to the management of obesity. Drugs. 1998;56:1093-124.
4. Hansen D, Astrup A, Toubro S, et al. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity: results from the European multi-centre STORM trial. Int J Obes. 2001;25:496-501.
5. Bray GA, Blackburn GL, Ferguson JM, et al. Sibutramine produces dose-related weight loss. Obes Res. 1999;7:189-98.
6. Heath MJ, Fitchet M. Initial weight loss as predictor of long term weight loss with sibutramine. Int J Obes. 1996;20:156 (abstr).
7. Appolinario JC, Godoy-Matos A, Fontenelle LF, et al. An open label trial of sibutramine in obese patients with binge-eating disorder. J Clin Psychiatry. 2002;63:28-30.
8. Rolls BJ, Shide DJ, Thorwart ML, Ulbrecht JS. Sibutramine reduces food intake in non-dieting women with obesity. Obes Res. 1997;6:1-11.
9. Womble L, Williamson DA, Greenway FL, Redmann SM. Psychological and behavioral predictors of weight loss during drug treatment for obesity. Int J Obes. 2001;25:340-345.
10. MacLachlan M, Connacher AA, Jung RT. Psychological aspects of dietary weight loss and medication with the atypical beta antagonist BRL 26830A in obese subjects. Int J Obes. 1990;15:27-35.
11. Elfhag K, Carlsson A-M, Rössner S. Subgrouping in obesity based on Rorschach personality characteristics. Scand J Psychol. 2003;44:399-407.
12. Exner JE. The Rorschach: A Comprehensive System, Volume 2, Current Research and Advanced Interpretation. 2nd ed. New York: John Wiley & Sons, 1991.
13. Exner JE. The Rorschach: A Comprehensive System, Volume I, Basic Foundations. 3rd ed. New York: John Wiley & Sons, 1993.
14. Nisbett RE, Wilson TD. Telling more than we can know: verbal reports on mental processes. Psychol Rev. 1977;84:231-59.
15. Allison DB, Heshka S. Emotion and eating in obesity? A critical analysis. Int J Eat Disord. 1993;13:289-95.
16. Elfhag K, Barkeling B, Carlsson A-M, Rössner S. Microstructure of eating behavior associated with Rorschach characteristics in obesity. J Pers Assess. 2003;81:40-50.
17. Elfhag K, Barkeling B, Carlsson A-M, Rössner S. Food intake with an anti-obesity drug (sibutramine) versus placebo and Rorschach data: a crossover within subject study. J Pers Assess. (in press).
18. Shimonaka Y, Nakazato K. Aging and terminal changes in Rorschach responses among the Japanese elderly. J Pers Assess. 1991;57:10-8.
19. Exner JE, Wylie JR, Leura AV, Parrill T. Some psychological characteristics of prostitutes. J Pers Assess. 1977;41:474-85.
20. Bornstein RF, Greenberg RP. Dependency and eating disorders in female psychiatric inpatients. J Nerv Ment Dis. 1991;179:148-52.
21. Narduzzi KJ, Jackson T. Personality differences between eating-disordered women and a nonclinical comparison sample: a discriminant classification analysis. J Clin Psychol. 2000;56:699-710.
22. Sprohge E, Handler L, Plant DD, Wicker D. A Rorschach study of oral dependence in alcoholics and depressives. J Pers Assess. 2002;79:142-60.
23. Bornstein RF. Comorbidity of dependent personality disorder and other psychological disorders: An integrative review. J Personal Disord. 1995;9:286-303.
24. Elfhag K, Rössner S, Carlsson A-M. Degree of body weight in obesity and Rorschach personality aspects of mental distress. Eat Weight Disord. (in press).
25. Renzi C, Pescatori M. Psychologic aspects in proctalgia. Dis Colon Rectum. 2000;43:535-9.
26. Bénoy H, Daloz L, Bungener C, Chahraoui K, Frenay C, Auvin J. Emotional factors and subjective quality of life in subjects with spinal cord injuries. Am J Phys Med Rehabil. 2002;81:437-45.
27. Weiner IB. Principles of Psychotherapy. 2nd ed. New York: Wiley, 1998.
28. Lucki I. The spectrum of behaviors influenced by serotonin. Biol Psychiatry. 1998;44:151-62.
29. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV. Washington, DC: American Psychiatric Association; 1994.
30. Rorschach, H. Psychodiagnostik. Bern, Switzerland: Bircher; 1921.
31. Cohen J. The cost of dichotomization. Applied Psych Measurement. 1998;7:249-53.
32. Beck AT, Ward CH, Mendelson M, Mock J, Erlbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.
33. National task force on the prevention and treatment of obesity. Weight cycling. JAMA. 1994;272:1196-202.
34. Barkeling B, Elfhag K, Rooth P, Rössner S. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome. Int J Obes. 2003;27:693-700.
35. Janson, H. Rorschach Research Utilities, 0.9.3 edn [unpublished computer software]. Oslo, Norway: University of Oslo, Institute of Psychology; 2002.
36. Janson H, Meyer GJ, Exner JE, Nakamura N, Tuset, AM. Computing Rorschach agreement among many coders on various data levels: an illustration with three international data sets. Proceedings of the XVII International Congress of Rorschach and Projective Methods. Rome, Italy; September 9-14, 2002.
37. Janson H, Olsson U. A measure of agreement for interval or nominal multivariate observations. Educ Psychol Meas. 2001;61:277-89.
38. Chiccetti DV, Sparrow SS. Developing criteria for establishing interrater reliability of specific items: applications of assessment of adaptive behavior. Am J Ment Defic. 1981;86:127-37.
39. Shrout P, Fleiss J. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86:420-8.
40. Curran PJ, West SG, Finch JF. The robustness of test statistics to nonnormality and specification error in confirmatory factor analysis. Psychol Methods. 1996;1:16-29.
41. Finer N, Bloom SR, Frost GS, Banks LM, Griffith J. Sibutramine is effective for weight loss and diabetes: a randomised, double-blind, placebo-controlled study. Diabetes Obes Metab. 2000;2000:105-12.
42. Hazenberg BP. Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients. Gen Cardiol. 2000;94:152-8.
43. Smith IG, Goulder MA. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity. J Fam Pract. 2001;50:505-12.
44. Bray GA, Ryan DH, Gordon D, Heidingsfelder S, Cerise F, Wilson K. A double-blind randomized placebo-controlled trial of sibutramine. Obes Res. 1996;4:263-70.
45. Blundell JE, Greenough A. Pharmacological aspects of appetite: implications for the treatment of obesity. Biomed Pharmacother. 1994;48:119-25.
46. Volume CI, Farris KB. Control with anorexiant medications. Can Fam Physican. 1998;44:2423-8.
47. Masling J, Price J, Goldband S, Katkin ES. Oral imagery and autonomic arousal in social isolation. J Pers Soc Psychol. 1981;40:395-400.
48. Masling J, O'Neill R, Katkin ES. Autonomic arousal, interpersonal climate, and orality. J Pers Soc Psychol. 1982;42:529-34.
49. Phelan S, Wadden TA. Combining behavioral and pharmacological treatments for obesity. Obes Res. 2002;10:560-74.
50. Finer N. Obesity. Clin Med. 2003;3:23-7.
51. Pasman WJ, Sarris WHM, Westerterp-Plantenga MS. Predictors of weight manitenance. Obes Res. 1999;7:43-50.
52. Mitchell J, Gosnell B, Roerig J, et al. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm. Obes Res. 2003;11:599-602.
53. Schachter S. Some extraordinary facts about obese humans and rats. Am Psychol. 1971;26:129-44.